LABORATORIOS FARMACEUTICOS ROVI, S.A. from 12/04/2021 to 12/04/2021 12/04/2021 08:35 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company publishes the press release concerning the extension of the collaboration that currently exists between ROVI and Moderna for the manufacture of the active substance of the COVID-19 Vaccine Moderna. Register number: 837